Trials / Conditions / NSCLC Stage IIIC
NSCLC Stage IIIC
5 registered clinical trials studyying NSCLC Stage IIIC — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Exercise in Patients With Advanced Non-small Cell Lung Cancer NCT06374160 | University Hospital, Essen | N/A |
| Active Not Recruiting | Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) NCT05816499 | Shanghai Chest Hospital | Phase 1 / Phase 2 |
| Terminated | Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Witho NCT04676386 | Addario Lung Cancer Medical Institute | — |
| Active Not Recruiting | Phase 2 Study of Dacomitinib in NSCLC NCT04027647 | National Cancer Centre, Singapore | Phase 2 |
| Terminated | Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumo NCT03805841 | Rain Oncology Inc | Phase 2 |